OK
The material selection platform
Cosmetics Ingredients
The material selection platform
Cosmetics Ingredients
by SpecialChem
 
Save
Cette page a bien été ajoutée à vos favoris

AC-AT

Allantoin. AC-AT by SOHO ANECO Chemicals is a skin conditioning agent and skin protectant. It is a diureide of glyoxylic acid. It is chemically synthesized, nature-identical, safe, non-toxic, compatible with cosmetic raw materials. As a moisturizer it helps to restore the soft and supple feeling to the skin. It accelerates wound healing through cell proliferation. This ingredient provides soothing, cleansing and healing of the skin and breaks up dandruff scales due to keratolytic action. It is effective at low concentration levels. AC-AT is used in various cosmetic preparations (skin conditioning agent) and pharmaceutical compounds (skin protectant). Also, used in face, body and hand creams/lotions, moisturizing creams/lotions, face powders, sun care, intensive treatment, lipsticks and pomades, rouges, make up-products, after-shave, shaving products, bath products, shampoo, sun-protection, toothpaste and mouthwash. The shelf life of this ingredient is 36 months.
download
Claims
  • Moisturizing Agents
  • Protective Agents
  • Conditioning Agents
  • wound healing
  • protections
  • softness
  • moisturizing
  • soothing
INCI Names

Compatiblity with other products

Find products that are predicted to be compatible with AC-AT.

This list of compatible products is generated out of estimated HSP values. A practical determination of these HSP values would provide higher certainty.
Learn more about Hansen Solubility Parameters (HSP) and their use in predictive formulation.

Want to list or
update your products?
Want to report errors or
suggest improvements?
Access Reliable
Product Information

Database of 51734 Cosmetics Ingredients,
reviewed and updated daily

Improve your Product
Selection Experience

Open your choices, compare products,
ask for samples, contact suppliers

Keep-up with latest
Technical Solutions

Be inspired and never miss again crucial
innovations with our weekly email updates

Back to Top